Skip to main content

Table 2 Data used to calculate the probability of CP

From: Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

 

MgSO4

No MgSO4

Source

Marrett

352

336

8

CP

22

30

 

Mittendorf

30

29

9

CP

3

0

 

Crowther

533

513

10

CP

36

42

 

Mild (GMFCS level I/II)

21

21

a

Moderate (GMFCS level III)

12

15

a

Severe (GMFCS level IV/V)

3

6

a

Rouse

1030

1107

11

CP

41

74

 

Mild (GMFCS level I/II)

28

49

b

Moderate (GMFCS level III)

8

9

b

Severe (GMFCS level IV/V)

5

16

b

  1. Total number of patients assessed and number with each outcome in each of the four trials. Note that only data on patients to whom magnesium sulphate was administered for the specific purpose of fetal neuroprotection was included in the present analyses.
  2. aAssumed with reference to the study protocol and detailed descriptions of characteristics for each GMFCS level for children under the age of four.
  3. bD. Rouse, MD, written communication, March 2011.
Back to article page